Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

ASCO: Pemetrexed extends survival as maintenance therapy

Dr. Chandra P. Belani - Penn State Cancer Institute, Hershey, Pennsylvania, USA

ASCO: Pemetrexed extends survival as maintenance therapy ( Dr. Chandra P. Belani - Penn State Cancer Institute, Hershey, Pennsylvania, USA )

ASCO: Trial compares common adjuvant treatments for pancreatic cancer

Dr. John Neoptolemos - University of Liverpool, Liverpool, UK

ASCO: Trial compares common adjuvant treatments for pancreatic cancer ( Dr. John Neoptolemos - University of Liverpool, Liverpool, UK )

ASCO: Surgery unnecessary for majority of patients with advanced colorectal...

Dr. Philip B. Paty - Memorial Sloan-Kettering Cancer Center, New York, USA

ASCO: Surgery unnecessary for majority of patients with advanced colorectal cancer ( Dr. Philip B. Paty - Memorial Sloan-Kettering Cancer Center, New York, USA )

ASCO: Lung cancer screening by low-dose computed tomography results in high...

Dr. Jennifer M. Croswell - National Institutes of Health, Bethesda, Maryland...

ASCO: Lung cancer screening by low-dose computed tomography results in high rate of false positives ( Dr. Jennifer M. Croswell - National Institutes of Health, Bethesda, Maryland, USA )

ASCO: Low rates of screening among childhood cancer survivors

Dr. Paul Nathan - Hospital for Sick Children, Toronto, Canada

ASCO: Low rates of screening among childhood cancer survivors ( Dr. Paul Nathan - Hospital for Sick Children, Toronto, Canada )

ASCO: Childhood cancer survivors at risk of post-traumatic stress disorder

Dr. Margaret Stuber - Los Angeles David Geffen School of Medicine, Los Angeles...

ASCO: Childhood cancer survivors at risk of post-traumatic stress disorder ( Dr. Margaret Stuber - Los Angeles David Geffen School of Medicine, Los Angeles, California, USA )

ASCO: Maintenance therapy for NSCLC

Dr. Vincent A. Miller - MD Memorial Sloan-Kettering Cancer Center, New York...

ASCO: Maintenance therapy for NSCLC ( Dr. Vincent A. Miller - MD Memorial Sloan-Kettering Cancer Center, New York, USA )

ASCO: Bevacizumab and standard adjuvant chemotherapy: no improvement in disease...

Dr Norman Wolmark - Chairman Dept of Human Oncology, Allegheny General Hospital...

ASCO: Bevacizumab and standard adjuvant chemotherapy: no improvement in disease-free survival for early-stage colon cancer ( Dr Norman Wolmark - Chairman Dept of Human Oncology, Allegheny General Hospital, US )

ASCO: Experimental targeted therapy improves progression-free survival for...

Dr Roy Herbst, M.D. Anderson Cancer Center, Houston, US

ASCO: Experimental targeted therapy improves progression-free survival for advanced NSCLC ( Dr Roy Herbst, M.D. Anderson Cancer Center, Houston, US )

Oestrogen and progestin therapy increases NSCLC risk

Dr Rowan Chlebowski - Harbor-UCLA Medical Center, Los Angeles, US

Oestrogen and progestin therapy increases NSCLC risk ( Dr Rowan Chlebowski - Harbor-UCLA Medical Center, Los Angeles, US )

AACR 2009: Circulating tumour cells as biomarkers

Dr Howard Scher - Sloan Kettering Memorial Cancer Center

AACR 2009: Circulating tumour cells as biomarkers ( Dr Howard Scher - Sloan Kettering Memorial Cancer Center )

NHS health care and the US health system

Exclusive interview with Professor Karol Sikora - Medical Director of Cancer...

NHS health care and the US health system ( Exclusive interview with Professor Karol Sikora - Medical Director of Cancer Partners UK )

More from ecancer